Bone Growth Stimulators Market Outlook (2023 to 2033)

The bone growth stimulators market size is projected to be valued at US$ 2.1 billion in 2023 and is expected to rise to US$ 5.4 billion by 2033. The sales of bone growth stimulators are expected to grow at a significant CAGR of 10.1% during the forecast period.

Various factors propelling the demand for bone growth stimulators are:

The market for bone growth stimulators is primarily driven by elements like the rising prevalence of bone and joint problems, the increased demand for minimally invasive and non-invasive surgeries globally, and the rising geriatric population.

The best feature of a bone growth stimulator is that it speeds up the entire process of bone healing, resulting in a faster recovery, shorter hospitalization, increased cost-effectiveness, and lesser infections.

Osteoarthritis is regarded as one of the most common articular diseases among people over the age of 65.

  • According to the World Population Prospects: The 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.

One of the key variables thought to be most likely to increase demand for the market under study is the rising prevalence of trauma and accident cases globally.

  • The National Safety Council estimates that 4.5 million persons suffered severe injuries in incidents in 2018.

The investments in healthcare infrastructure have given the market leaders in bone growth stimulators an opportunity to create their mark by introducing products that stand out and take over the majority of revenue share.

According to the Centers for Disease Control and Prevention, an estimated 34.6 million adults will have arthritis-related activity limitations by 2040. This has resulted in a growing preference for active and healthy lifestyles, creating a demand for faster injury-healing processes.

Additionally, ongoing product developments and advancements are expected to drive demand for bone growth stimulators in the coming years.

Attributes Details
Bone Growth Stimulators Market CAGR 10.1%
Bone Growth Stimulators Market Valuation (2023) US$ 2.1 billion
Bone Growth Stimulators Market Valuation (2033) US$ 5.4 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed till June 2022?

Market Statistics Details
H1,2021 (A) 9.54%
H1,2022 Projected (P) 9.94%
H1,2022 Outlook (O) 9.74%
BPS Change: H1,2022 (O) - H1,2022 (P) (-) 20 ↓
BPS Change: H1,2022 (O) - H1,2021 (A) (+) 50 ↑

According to FMI analysis, the market growth rate comparison analysis for the H1-2022 outlook and H1-2022 projected period showed a declining aspect of the market with the change in BPS of nearly 20 BPS.

The adoption rate of bone growth stimulator devices has decreased as a result of their high cost and physicians' lack of confidence in device efficacy. This is a key cause of the decline in the BPS value. Different units of stimulation strength, varied stimulation protocols, and inadequate device specification reporting are further contributing causes to the BPS decline.

However, the bone growth stimulators market is expected to show incremental growth in H1- 2022 when compared to H1-2021 as shown by the spike in BPS value by 20 Basis Point Share (BPS). Recent developments in the market including the innovation of products like the AccelStim bone growth stimulator which emits high-frequency sound wave (ultrasound signal) promoting bone growth and assisting in the healing of damaged bones proposes positive growth in the near future.

2013 to 2021 Bone Growth Stimulators Market Outlook in Comparison to 2023 to 2033 Growth Forecast

Market to witness an absolute dollar growth of USD 3.4 billion between comparison period

Demand is projected to increase at a healthy 10.1% CAGR between 2023 to 2033, in comparison with the 9.3% CAGR registered between 2013 to 2031, finds Future Market Insights (FMI).

Increasing preference for non-invasive and minimally invasive surgical procedures is expected to boost the market in the forthcoming years. The rising incidence of osteoporosis among the geriatric population, along with surging rates of sports-related orthopedic injuries are underpinning the demand in the market.

Osteoarthritis (OA) is one of the most common forms of arthritis. As per the statistics availed by the Centers for Disease Control and Prevention (CDC), over 32.5 million USA adults are affected by osteoarthritis each year.

The growing incidence of such disorders is compelling manufacturers to launch advanced bone growth stimulators in the market. These devices stimulate the natural healing of bones by sending low-level pulses of electromagnetic energy to the fusion or injured site.

These products are beneficial for post-multi-level fusion procedures, and for patients who have comorbidities such as diabetes and substance addiction.

Further, there has been an uptick in research and development efforts regarding novel treatment options and techniques by bone growth stimulator market players. Favorable government policies and increasing investments by commercial organizations will continue augmenting the growth of the market over the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How Growing Preference for Non-Invasive Surgeries is Fueling Sales of Bone Growth Stimulators?

Surging demand for minimally invasive procedures due to their benefits over traditional procedures is expected to push sales in the market. Key advantages of such procedures include fewer complications in operations, shorter hospitalization, reduced pain, lower risk of infections, and faster recovery.

Taking cues, manufacturers are launching innovative platelet-rich plasma (PRP) and bone morphogenetic proteins (BMP) products to aid bone formation during various fractural and spiral operations. These products help in faster healing and recovery, which is expected to boost sales in the market.

Rising incidence of trauma injuries and accident-related fractures are propelling the rates of spinal and orthopedic procedures, thereby spurring demand for bone growth stimulators for humerus fractures.

Further, capacitive coupling bone growth stimulator devices are widely being adopted with implanted biomedical systems for customized electrical stimulation. This has resulted in the popularity of electromagnetic simulation, which uses direct current coupling, capacitive coupling, and inductive coupling.

As per FMI, the growing preference for these surgeries in emerging economies such as India, China, and Brazil is expected to augment the growth in the bone growth stimulators market. Factors such as increasing expenditure on healthcare, government investments in the expansion of the healthcare sector, and growing awareness among patients and healthcare providers regarding minimally invasive surgeries are expected to boost the market in the forthcoming years.

Country-wise Analysis

Asia-Pacific’s untapped regions are getting the spotlight in the global market

The bone growth stimulators market in several Asia-Pacific countries is expected to grow rapidly during the forecast period, owing to an aging population, rapid economic growth in emerging Asia-Pacific (APAC) countries, and an increase in the volume of spine procedures.

In China, the increasing prevalence of cervical (neck) and lumbar (lower back) spine surgeries highlights the significance of advanced combined magnetic field (CMF) devices for bone growth stimulation therapy.

In China, healthcare professionals are recommending these devices to be worn after lumbar and cervical surgeries to help with pain relief. These devices are also used to improve spine bone fusion following fusion procedures and as a treatment for failed fusion surgeries.

Attribute Details
China Market Size (US$ million/billion) by End of Forecast Period (2033) US$ 229.8 million
China Market Absolute Dollar Growth (US$ million/billion) US$ 148.1 million
CAGR % 2017 to 2022 10.3%
CAGR % 2023 to End of Forecast (2033) 10.8%

At a CAGR of 11.4%, India is expected to be the fastest-growing market in the APAC region. Improvements in the country's healthcare landscape will drive growth.

Access to healthcare is a significant barrier for Indian patients, particularly those with lower incomes. The government has taken a number of steps to improve the healthcare system, including ensuring that more than 95% of the population is covered in some way.

Furthermore, government reimbursement policies favor domestically produced devices by providing high reimbursement rates.

Attribute Details
India Market Size (US$million/billion) by End of Forecast Period (2033) US$ 82.3 million
India Market Absolute Dollar Growth (US$ million/billion) US$ 54.4 million
CAGR % 2017 to 2022 10.3%
CAGR % 2023 to End of Forecast (2033) 11.4%

The high availability of modern equipment and technologies is bolstering USA market growth

By 2033, it is expected that the USA market for bone growth stimulators will exceed USD 2.2 billion. The high adoption of modern bone growth stimulator devices, the rise in bone illnesses, the presence of significant manufacturers in the nation, and other reasons are primarily responsible for this majority market share. The high prevalence of joint conditions like osteoporosis, arthritis, and rheumatoid arthritis among others in the United States is expected to favor market expansion.

Attribute Details
USA Market Size (US$million/billion) by End of Forecast Period (2033) US$ 2.2 billion
USA market Absolute Dollar Growth (US$ million/billion) US$ 1.4 billion
CAGR % 2017 to 2022 9.9%
CAGR % 2023 to End of Forecast (2033) 10.7%

High awareness of minimally invasive surgeries is driving the United Kingdom market

With a growing demand for minimally invasive procedures and an increase in medical tourism, the United Kingdom is predicted to dominate the European bone growth stimulators market in the years to come. In 2022, sales are anticipated to hold a 20.4% share of the global market.

Medical tourism has increased somewhat as a result of the country's availability of top-notch healthcare facilities. The anticipated continuation of this trend will increase demand for bone growth stimulators in the years to come.

Additionally, patients are actively favoring magnetic and ultrasound bone growth stimulators. To meet the expanding demand, local manufacturers have introduced efficient and cutting-edge solutions.

Attribute Details
United Kingdom Market Size (US$million/billion) by End of Forecast Period (2033) US$ 173.8 million
United Kingdom Market Absolute Dollar Growth (US$ million/billion) US$ 101.2 million
CAGR % 2017 to 2022 8.7%
CAGR % 2023 to End of Forecast (2033) 9.1%

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Bone Growth Stimulators Market - Category-wise Insights

The growing prevalence of joint disorders is feeding the segment’s growth

The prevalence of bone and joint disorders is expected to drive industry growth in the coming years. The rapidly growing elderly population suffering from this disease condition has increased demand for trauma & maxillofacial surgeries, positively influencing the bone growth stimulators market growth. Joint disorders, including osteoarthritis, are among the most common diseases among people aged 65 and older.

Rapid technological advancements in these devices are positively stimulating product adoption. These advancements in external and ultrasonic bone growth stimulators for accelerating the healing of indicated bone, as well as several other breakthroughs, have increased the procedure's outcome and success rate.

Top Application Trauma Injury and Fractures
CAGR % 2017 to 2022 9.7%
CAGR % 2023 to End of Forecast (2033) 10.4%

Rapid infrastructural developments to provide growth prospects to the hospital segment

By 2028, the hospital segment is expected to be worth more than USD 743 million. This high market share is largely due to the growing patient preference for quality care at an affordable price. The availability of a wide range of orthopedic treatments incorporating advanced bone growth stimulators to cater to the patient population is also helping to drive market growth.

Hospitals are also emphasizing the delivery of various comprehensive programs with personalized and professional support in the management of target diseases. Similarly, the increasing adoption and release of user-friendly and cost-effective bone growth stimulators for use in hospitals are important factors driving product demand.

Top End Use Hospitals
CAGR % 2017 to 2022 9.2%
CAGR % 2023 to End of Forecast (2033) 10.0%

Manufacturers are constantly evolving to increase their global presence

The market for bone growth stimulators is highly consolidated and dominated by global players. With the increasing prevalence of orthopedic diseases and technological advancements, a small number of small to mid-sized companies are entering the market. Medtronic plc, Johnson and Johnson (Depuy Synthes), Bioventus LLC, Orthofix International N.V., Zimmer Biomet, and Stryker Corporation are among the market's key players. Furthermore, as product availability increases, global players' expansion strategies are proving beneficial to the emerging market.

  • Orthofix announced an exclusive license agreement in April 2021 to commercialize IGEA's bone, soft tissue, and cartilage stimulator product portfolio in the United States and Canada. This agreement enabled the company to broaden its portfolio of bone growth therapies across multiple care settings.
  • Medtronic acquired Stimgenics in January 2020 to expand its portfolio in Differential Target Multiplexed Spinal Cord Stimulation Therapy.

Some of the leading companies operating in the Bone Growth Stimulators Market are

  • Zimmer Biomet Holdings Inc
  • Bioventus LLC.
  • DJO Global, Orthofix Holdings, Inc.
  • Ossatec Benelux Ltd.
  • IGEA
  • Ito Co., Ltd.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered USA, Canada, Germany, United Kingdom., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered Application, Product Type, End Use, Region
Key Companies Profiled Zimmer Biomet Holdings Inc; Bioventus LLC.; DJO Global, Orthofix Holdings, Inc.; Ossatec Benelux Ltd.; IGEA; Ito Co., Ltd.
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Bone Growth Stimulators Market by Category

Product Type:

  • Non-Invasive Bone Growth Stimulators
  • Capacitive Coupling (CC) Devices
  • Pulsed Electromagnetic Field (PEMF) Devices
  • Combined Magnetic Field (CMF) Devices
  • Ultrasound Bone Growth Stimulators
  • Invasive Bone Growth Stimulators

Application:

  • Trauma Injury and Fractures
  • Spinal Fusion
  • Osteogenesis

End User:

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Homecare settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Frequently Asked Questions

What Fuels the Bone Growth Stimulators Market?

The rising prevalence of bone and joint problems increases the demand of the market.

Who are the Key Players in the Bone Growth Stimulators Market?

Ossatec Benelux Ltd., IGEA, and Ito Co., Ltd. are the key market players.

What is Driving Sales in the Asia Pacific Market?

An increase in the volume of spine procedures drives the Asia Pacific market.

What is the Market Valuation in 2023?

This market is valued at US$ 2.1 billion in 2023.

What is the United States Bone Growth Stimulators Market Outlook?

The United States market is projected to expand at 10.7% CAGR from 2023 to 2033.

Table of Content

1. Executive Summary | Bone Growth Stimulators Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2023 to 2033 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ million) Analysis, 2023 to 2033

    4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2023 to 2033

    5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Noninvasive Electrical

            5.3.1.1. Capacitive Coupling Devices

            5.3.1.2. Pulsed Electromagnetic Field Devices

            5.3.1.3. Combined Magnetic Field Devices

        5.3.2. Invasive Electrical

        5.3.3. Ultrasound

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2023 to 2033

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) Analysis By Application, 2023 to 2033

    6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Trauma Injury and Fractures

        6.3.2. Spinal Fusion

        6.3.3. Osteogenesis

    6.4. Y-o-Y Growth Trend Analysis By Application, 2023 to 2033

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By End Use

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ million) Analysis By End Use , 2023 to 2033

    7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End Use , 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Orthopedic Clinics

        7.3.4. Home Care

    7.4. Y-o-Y Growth Trend Analysis By End Use , 2023 to 2033

    7.5. Absolute $ Opportunity Analysis By End Use , 2023 to 2033

8. Global Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ million) Analysis By Region, 2023 to 2033

    8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. Asia Pacific excluding Japan (APEJ)

        8.3.6. Japan

        8.3.7. Middle East and Africa (MEA)

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Application

        9.2.4. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Application

        9.3.4. By End Use

    9.4. Key Takeaways

10. Latin America Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By End Use

    10.4. Key Takeaways

11. Western Europe Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Italy

            11.2.1.5. Spain

            11.2.1.6. BENELUX

            11.2.1.7. Nordic Countries

            11.2.1.8. Rest Of Western Europe

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By End Use

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Russia

            12.2.1.2. Poland

            12.2.1.3. Rest Of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By End Use

    12.4. Key Takeaways

13. APEJ Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. India

            13.2.1.3. Australia & New Zealand

            13.2.1.4. ASEAN

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By End Use

    13.4. Key Takeaways

14. Japan Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

        14.2.2. By Product Type

        14.2.3. By Application

        14.2.4. By End Use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By End Use

    14.4. Key Takeaways

15. MEA Market Analysis 2023 to 2033 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2023 to 2033

    15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Rest Of MEA

        15.2.2. By Product Type

        15.2.3. By Application

        15.2.4. By End Use

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Application

        15.3.4. By End Use

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Application

            16.1.2.3. By End Use

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Application

            16.2.2.3. By End Use

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Application

            16.3.2.3. By End Use

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Application

            16.4.2.3. By End Use

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Application

            16.5.2.3. By End Use

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Application

            16.6.2.3. By End Use

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Application

            16.7.2.3. By End Use

    16.8. Italy

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Application

            16.8.2.3. By End Use

    16.9. Spain

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Application

            16.9.2.3. By End Use

    16.10. BENELUX

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Application

            16.10.2.3. By End Use

    16.11. Nordic Countries

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Application

            16.11.2.3. By End Use

    16.12. Russia

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Application

            16.12.2.3. By End Use

    16.13. Poland

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Application

            16.13.2.3. By End Use

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Application

            16.14.2.3. By End Use

    16.15. India

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Application

            16.15.2.3. By End Use

    16.16. Australia & New Zealand

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Application

            16.16.2.3. By End Use

    16.17. Japan

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Application

            16.17.2.3. By End Use

    16.18. GCC Countries

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Application

            16.18.2.3. By End Use

    16.19. South Africa

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Application

            16.19.2.3. By End Use

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Application

        17.3.4. By End Use

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Zimmer Biomet Holdings Inc

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Bioventus LLC.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. DJO Global, Orthofix Holdings, Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Ossatec Benelux Ltd.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. IGEA

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Ito Co., Ltd.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Isto Biologics

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Medtronic PLC

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Elizur Corporation

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Kinex Medical Company, LLC

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Bone Densitometer Devices Market

August 2023

REP-GB-733

345 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Bone Growth Stimulators Market

Schedule a Call